کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
8486804 | 1551779 | 2011 | 4 صفحه PDF | دانلود رایگان |
عنوان انگلیسی مقاله ISI
Immunogenicity and safety of a pediatric dose virosomal hepatitis A vaccine in Thai HIV-infected children
دانلود مقاله + سفارش ترجمه
دانلود مقاله ISI انگلیسی
رایگان برای ایرانیان
کلمات کلیدی
موضوعات مرتبط
علوم زیستی و بیوفناوری
ایمنی شناسی و میکروب شناسی
ایمونولوژی
پیش نمایش صفحه اول مقاله
![عکس صفحه اول مقاله: Immunogenicity and safety of a pediatric dose virosomal hepatitis A vaccine in Thai HIV-infected children Immunogenicity and safety of a pediatric dose virosomal hepatitis A vaccine in Thai HIV-infected children](/preview/png/8486804.png)
چکیده انگلیسی
The immunogenicity and safety of a pediatric dose of a virosomal hepatitis A vaccine (Epaxal®) was evaluated in a group of 45 Thai children with human immunodeficiency virus (HIV) infection, age 2-16 years. Vaccines were administered at 0 and 6 months. Anti-HAV antibody titers were measured at baseline (before injection) 1 and 7 months after primary vaccination. The prevalence of HAV protective antibody in 45 Thai HIV-infected children was 13.6%. The seroprotection rate was 71% at 1 month and 100% at 7 months. The booster dose increased geometric mean concentration (GMC) from 106.5Â mIU/ml to 3486.1Â mIU/ml. Higher CD4 lymphocyte counts at enrollment was a predictive factor for HAV antibody response. Both doses of Epaxal® were well tolerated. These preliminary data suggest that a pediatric dose of Epaxal® is an effective hepatitis A vaccine for HIV-infected children and should be considered for implementation on a larger scale in the pediatric HIV population.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Vaccine - Volume 29, Issues 29â30, 24 June 2011, Pages 4735-4738
Journal: Vaccine - Volume 29, Issues 29â30, 24 June 2011, Pages 4735-4738
نویسندگان
Rachanee Saksawad, Sasithorn Likitnukul, Boonyarat Warachit, Orrawadee Hanvivatvong, Yong Poovorawan, Panitchaya Puripokai,